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Primary seminal vesicle (SV) adenocarcinoma is a rare tumor. A small amount of data about the role of imaging to detect tumor 
recurrence is available. We report the case of a 58-year-old patient with primary SV clear-cell well-differentiated 
adenocarcinoma. Clinical and instrumental examinations were negative for the 32 months after treatments when computed 
tomography scan, [18F]fluoro-D-glucose positron emission tomography/computed tomography and pelvic magnetic resonance 
imaging showed the appearance of a lesion in the left perineal muscle suspected for recurrence. Patient was symptomless. 
Cytology of the suspected lesion confirmed SV adenocarcinoma recurrence. The combined approach, using radiological and 
nuclear medicine techniques, seems to be effective in the follow-up of SV adenocarcinoma. Technological advances, together 
with awareness of this rare tumor, have the potential of improving patients outcomes not only by providing earlier detection and 
accurate staging, but also by detecting recurrence and thereby avoiding delays and therapeutic dilemmas.
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　Primary adenocarcinoma of the seminal vesicle (SV) is 
very rare and poorly understood neoplasm with approx-
imately 60 documented cases reported in the literature, in-
cluding adenocarcinoma (the most commonly seen malig-
nant tumor), cystadenoma, and mesenchymal tumor (the 
most commonly seen benign tumor) [1]. The prognosis is 
generally poor, and approximately 95% of the patients die 
in less than 3 years [2].
　The symptoms are generally non-specific, including blad-
der outlet obstruction, hematuria, hematospermia, dysuria, 
and painful sensation in the pelvis and perineum [3]. 
　Given the rarity of these tumors, there are no estab-
lished staging or treatment guidelines. The original diag-
nostic criteria of SV tumors were later modified by Benson 
et al [2]. Radiological imaging plays a crucial role in the as-
sessment of SV tumors to confirm the presence of the le-
sion and to evaluate the extent of SV involvement. 
Usually, they appear as poorly circumscribed solid or cyst-
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Fig. 1. Computed tomography (CT) images show two lesions suspected for seminal vesicle recurrence. Transaxial CT images show the 
lesion of the left transverse perineal muscle (arrow in A) associated with a thickening of the posterior wall of the bladder (arrow in B).
ic masses that may be misinterpreted as an abscess or hem-
orrhage [1]. Radiology can also help to detect a primary le-
sion or any associated congenital genitourinary malforma-
tions such as ectopic ureters or renal agenesis [3]. 2-de-
oxy-2-([18]F)fluoro-D-glucose positron emission tomog-
raphy/computed tomography ([18F]FDG-PET/CT) has been 
used in the case of SV cancer to stage disease, particularly 
to exclude distant metastases [3,4] and to assess treatment 
response [4]. Different from radiological imaging that pro-
vides anatomical and morphological data, [18F]FDG-PET/ 
CT characterizes the biological properties of a tumor, de-
picting lesions with enhanced metabolism. Surgical ex-
cision, ranging from local excision or vesiculectomy alone 
to pelvic exenteration depending on the extent of involve-
ment of the adjacent organs, is the mainstay of treatment. 
Radiotherapy, multiagent chemotherapy, and androgen 
deprivation therapy may also be beneficial in the adjuvant 
or palliative setting [5].
CASE REPORT
　We present the case of a 58-year-old patient with re-
currence of SV clear-cell adenocarcinoma associated with 
right renal agenesis. Since 2006, the patient had suffered 
from recurrent hematospermia. Serum tumor markers in-
cluding prostate-specific antigen (PSA), neuron-specific 
enolase, carcinoembryonic antigen (CEA), carbohydrate 
antigen 19-9 (CA-19.9), alpha-fetoprotein, and chromog-
ranin A were negative. Transrectal ultrasound and pelvic 
magnetic resonance imaging (MRI) diagnosed bilateral 
congenital SV cysts. In 2009, a transrectal ultra-
sound-guided biopsy of the SV was performed due to the 
persistence of intermittent hematospermia, resulting 
negative. Since 2010, the patient had also presented epi-
sodes of hematuria. No atypical cells were identified in the 
urinary cytological examination. Cystoscopy was neg-
ative; thus, the transrectal ultrasound-guided biopsy of SV 
was repeated. In the same examination, a bioptical map-
ping of the prostate was also done. The histology results 
were consistent with SV adenocarcinoma. Staging exami-
nations included a contrast-enhanced CT scan, [18F]FDG- 
PET/CT imaging, and bone scintigraphy. In the CT scan, 
the primary SV lesion was characterized by a hypodense 
central area presenting peripheral contrast enhancement. 
Further, a left pararectal lymph node (size: 16 mm) was 
visualized. [18F]FDG-PET/CT confirmed radiopharmaceu-
tical uptake in the primary SV lesion and in the pararectal 
lymph node (SUVmax=7.3 and 4.9, respectively). The 
bone scan was negative. In May 2010, the patient was sur-
gically treated (prostatectomy plus pelvic lymphadenec-
tomy plus bilateral vesiculectomy). Definitive histology 
confirmed primary bilateral SV clear-cell well-differ-
entiated adenocarcinoma with a tubulo-papillary growth 
infiltrating the stroma. In the prostate, normal prostatic tis-
sue was not found. The pararectal lymph node resulted 
metastatic. Immunohistochemistry showed a strong pos-
itivity for cytokeratin 7 (CK7), epithelial membrane anti-
gen, and p53, and was negative for PSA, carbohydrate an-
tigen 125 (CA-125), cytokeratin 20 (CK20), caudal-type 
homeobox protein 2 (CDX2), and CEA. 
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Fig. 2. [18F]fluoro-D-glucose positron emission tomography/computed tomography ([18F]FDG-PET/CT) images show the lesion 
suspected for seminal vesicle recurrence. Maximum intensity projection image shows an area of moderate [18F]FDG uptake under the
bladder (arrow in A). Transaxial [18F]FDG-PET/CT images show a central ‘cold’ area and peripheral [18F]FDG uptake at left transverse
perineal muscle (arrow in B) as confirmed by images repeated immediately after urination (arrow in C).
Fig. 3. Magnetic resonnace imaging (MRI) images show two lesions suspected for seminal vesicle recurrence. Transaxial MRI images
show the lesion of the left transverse perineal muscle characterized by a high signal intensity in T2-weighted (arrow in A) and the 
thickening of the posterior wall of trigone of the bladder in T1-weighted image (arrow in B).
　Thereafter, the patient underwent adjuvant chemo-
therapy (cisplatinum plus gemcitabine) and intensity- 
modulated radiation therapy (60 gray). During the first 
year of follow-up, the patient was followed up by clinical 
examination, serum tumor markers, and contrast-enhan-
ced CT scan (chest and abdomen) every 3 months. No 
hematospermia or hematuria occurred. All examinations 
showed negative results. Thereafter, clinical and radio-
logical examinations were performed every 6 months and 
all of them showed negative results. In January 2013, a 
contrast-enhanced CT scan showed the appearance of a 
lesion (size: 24×15×42 mm) in the left transverse peri-
neal muscle characterized by a hypodense central area 
with peripheral contrast enhancement (Fig. 1). A thicken-
ing of the posterior wall of the bladder was also found. 
These findings were considered suspicious for tumor re-
currence; thus, an [18F]FDG-PET/CT scan was performed. 
In the PET/CT, the lesion of the left transverse perineal 
muscle was characterized by a central ‘cold’ area and pe-
ripheral [18F]FDG uptake (SUVmax=4.5), a finding con-
firmed by the additional acquisition of the pelvis repeated 
at the end of the whole-body scan, immediately after uri-
nation, performed to better visualize the pelvic region 
(SUVmax=5.8), as shown in Fig. 2. [18F]FDG-PET/CT did 
not reveal any other pelvic lesions or distant metastasis. A 
pelvic MRI was also performed. The lesion of the left trans-
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verse perineal muscle presented a high signal intensity in 
T2-weighted images and a low signal intensity in the 
T1-weighted images, along with wall contrast enhance-
ment after a gadolinium injection, without any cleavage 
plane with the rectum (Fig. 3). Further, thickening of the 
posterior wall of the trigone of the bladder was confirmed 
presenting an internal small hemorrhagic area. The MRI 
findings were considered suspicious for tumor recurrence 
although the presence of an abscess could not be ruled out 
with certainty. The patient did not present any signs or 
symptoms, and the clinical examination as well as serum 
tumor markers consistently showed negative results. A 
transrectal ultrasound-guided cytology of the left trans-
verse perineal muscle lesion was performed in February 
2013, confirming the recurrence of SV clear-cell ad-
enocarcinoma. Thus, a chemotherapy regimen with taxol 
plus carboplatinum (6 cycles) was started, and the patient 
is currently in follow-up.
DISCUSSION
　We present a case of the usefulness of imaging to detect 
the recurrence of primary SV clear-cell well-differentiated 
adenocarcinoma.
　Diagnosis of SV adenocarcinoma is difficult and is 
based on a correlation of clinical, radiological, and histo-
logical findings. 
　Histology is central in this clinical setting, despite the lack 
of an organ-specific immunophenotype. All reports pub-
lished about the immunohistochemistry of SV cancers have 
revealed that these tumors are negative for PSA. The staining 
for CK7 has usually been strongly positive and that for CK20, 
negative. The keratin profile might be helpful in distinguish-
ing SV adenocarcinoma from prostate, colorectal, and ur-
othelial-type bladder carcinomas [1,5,6]. In our case, 
CA-125 was negative, similar to other reports, although cas-
es positive for CA-125 have also been described [5]. 
　Imaging plays a crucial role in identifying primary SV 
adenocarcinoma. In the imaging, these tumors appear as a 
mass behind the bladder with or without a prostatic or ure-
teral obstruction or as an infiltrating lesion in the SV with 
enhancement similar to that of advanced prostate cancer 
[7]. Further, imaging can identify renal agenesis or dys-
genesis that may be associated with both SV cysts and tu-
mors [8]. Our patient, one year before the diagnosis of SV 
adenocarcinoma, was diagnosed with a bilateral con-
genital SV cyst associated with right renal agenesis. SV 
cysts are commonly associated with renal agenesis or 
dysgenesis. Incomplete development between the 
Wolffian duct and the urogenital sinus in males results in 
an accumulation of secretions and the subsequent for-
mation of SV cysts during puberty [9]. Lee et al [8] sug-
gested that the cause of large SV cysts is not only the ec-
topic ureter opening into the cyst but also a mucin-produc-
ing tumor. On the basis of these premises and our case, we 
suggest a radiological follow-up of patients with SV cyst, 
particularly when hematospermia and hematuria are pres-
ent, in order to eventually detect early SV tumors. 
　There is little data about the role of imaging in the fol-
low-up of SV adenocarcinoma [4]. In our case, the re-
currence of SV adenocarcinoma in the left transverse peri-
neal muscle presented the same characteristic of primary 
lesion in both contrast-enhanced CT and [18F]FDG-PET/CT; 
thus, tumor recurrence was suspected. Further, the pelvic 
MRI findings were considered suspicious although the pres-
ence of an abscess could not be ruled out with certainty. 
Both contrast-enhanced CT scan and pelvic MRI also re-
vealed the thickening of the posterior bladder wall, while 
[18F]FDG-PET/CT did not show any uptake at this level. 
Although cytological confirmation of the recurrence of SV 
adenocarcinoma was obtained only in the left transverse 
perineal muscle lesion, we cannot exclude the tumor in-
volvement of the posterior bladder wall. In fact, with the ex-
cretion of [18F]FDG by the kidney into the urine, intense 
normal [18F]FDG activity is observed in the intrarenal col-
lection systems, ureters, and bladder, and the urinary ex-
cretion of [18F]FDG continued in well-hydrated patients 
even 1 hour after [18F]FDG administration [10]. Thus, 
[18F]FDG-PET/CT may give a false negative result in the de-
tection of the recurrence of a bladder tumor. Nevertheless, 
[18F]FDG-PET/CT allows one to exclude distant metastases. 
　To summarize, here, we report a case of primary SV 
clear-cell adenocarcinoma associated with right renal 
agenesis, recurred after treatments, depicted in both radi-
ology and [18F]FDG-PET/CT. Imaging results were very 
useful in reaching the final diagnosis. In fact, from a clin-
ical point of view, the patient did not present any suspi-
cious signs or symptoms for the recurrence of SV ad-
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enocarcinoma, and both the clinical examination and the 
tumor markers were yielded negative results. The sim-
ilarity between the lesion of the left transverse perineal 
muscle and the primary SV lesion in both the CT scan and 
[18F]FDG-PET/CT together with the concordance of the 
findings of both radiological and nuclear medicine techni-
ques led to a strong suspicion of tumor recurrence. 
　As illustrated by our case, a combined approach using 
radiology and nuclear medicine techniques seems to be 
effective in the follow-up of SV adenocarcinoma patients 
to early diagnose tumor recurrence. Technological ad-
vances in imaging and histopathology, together with the 
awareness of this rare tumor, have the potential of improv-
ing the outcomes in these patients not only by providing 
earlier detection and accurate staging, but also by detect-
ing recurrence and thereby avoiding delays and ther-
apeutic dilemmas.
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